AMALGAMATED BANK - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-55.0%
8,3140.0%0.00%
Q2 2023$40
-39.4%
8,314
-28.5%
0.00%
-100.0%
Q1 2023$66
-51.1%
11,634
-13.0%
0.00%0.0%
Q4 2022$135
-100.0%
13,3780.0%0.00%
-66.7%
Q3 2022$300,000
-8.0%
13,378
+1.6%
0.00%0.0%
Q2 2022$326,000
-36.7%
13,163
-0.9%
0.00%
-25.0%
Q1 2022$515,000
-69.2%
13,286
-53.5%
0.00%
-33.3%
Q4 2021$1,672,000
+95.3%
28,568
+97.9%
0.01%
-14.3%
Q3 2021$856,000
-34.9%
14,436
-4.7%
0.01%
-36.4%
Q2 2021$1,314,000
+47.0%
15,141
+39.7%
0.01%
-67.6%
Q1 2021$894,000
-12.2%
10,841
-3.2%
0.03%
-12.8%
Q4 2020$1,018,000
+128.8%
11,195
+0.5%
0.04%
+105.3%
Q3 2020$445,000
+29.4%
11,141
+11.1%
0.02%
+18.8%
Q2 2020$344,000
+41.0%
10,025
-8.7%
0.02%
+166.7%
Q1 2020$244,000
+7.0%
10,985
-5.7%
0.01%
+50.0%
Q4 2019$228,00011,6530.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders